Our IP specialists work at all stage of the IP life cycle and provide strategic advice about patent, trade mark and registered designs, as well as any IP-related disputes and legal and commercial requirements.
OUR PEOPLE
ADAM GREGORY
Partner, Patent Attorney
Life Sciences
Manchester
News & Insights
We want to keep you up to date with developments in the IP world and let you know what we are up to at Mewburn Ellis.
Law & Practice Guides
We believe in making it easy for you to find the information that you want – and you can always contact us if you can’t find what you need.
Blogs by Author
Adam works with biotech companies to build and manage their patent portfolios, drafting patent applications and co-ordinating prosecution worldwide. He has particular experience advising clients in relation to strategy for protecting therapeutics (particularly immunotherapies, including adoptive cellular therapies), novel antibody technologies, diagnostics, and cellular agriculture inventions.
Adam leads our future food team which focuses on alternative protein technologies. He is a regular contributor to the wider conversation around protecting innovation in this exciting field.
Areas of Technical Expertise
- Immunology
- Molecular and Cellular Biology
- Cancer
- Neurology
- Infectious and Autoimmune disease
- Cell culture
- Stem cell technology
- Genetic engineering
Clients
Adam’s clients are based in Singapore, Europe and the US, and include biotech start-ups and SMEs, academic institutions, governmental organisations and multinational biotech corporations.
Background
Adam has a first class degree in Biological Sciences from the University of Oxford, and a D.Phil. in Clinical Medicine from the University of Oxford.
He joined Mewburn Ellis LLP in 2012, qualifying as a Chartered Patent Attorney and a European Patent Attorney in 2016, and became a Partner in 2020.
Recommendations
Adam has been listed as a "key lawyer" in the 2021 and 2023 editions of The Legal 500.